Deanna L. Kirkpatrick

Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the $100 million initial public offering of common stock of Magenta…

Davis Polk advised the underwriters in connection with an initial public offering of 7,359,998 shares of common stock of Aptinyx Inc., at $16.00 per share (which includes the exercise in…

Davis Polk advised the lead managers on an SEC-registered offering by TD Bank of (i) $500 million aggregate principal amount of its 3.000% senior notes due 2020, (ii) $900 million…

Davis Polk advised the representatives of the underwriters in connection with the SEC-registered offering of 24,640,000 shares of common stock of Melinta Therapeutics, Inc., including…

Davis Polk advised the Province of New Brunswick in connection with the offering of $500 million aggregate principal amount of 3.625% bonds due February 24, 2028. The Davis Polk team…

Davis Polk advised the representatives of the several underwriters in connection with the registered offering of £250 million aggregate principal amount of 2.750% senior notes due 2025. DXC…

Davis Polk advised the underwriters in connection with the offering of $1 billion aggregate principal amount of 2.750% U.S. dollar bonds due 2023 issued by Export Development Canada…

Davis Polk advised the underwriters in connection with the SEC-registered offering of $1.25 billion aggregate principal amount of 3.300% bonds due March 15, 2028, issued by the Province of…

Davis Polk advised the joint book-running managers in connection with the $80 million public offering of common stock of Dova Pharmaceuticals, Inc. The common stock is listed on the NASDAQ…

Davis Polk advised the underwriters in connection with the offering of $3 billion aggregate principal amount of 2.550% bonds due February 12, 2021 issued by the Province of Ontario.  …